When CVS discovered that prices listed for brand-name drugs on its SilverScript Medicare site were mistakenly displayed at about 4% less than the drugs were actually being sold for, the company quickly fixed the glitch, according to a report in today’s Wall Street Journal. But what happened to customers who saw the “low” prices and ended up paying more at retail? According to The Journal, CVS cut a deal with the government, allowing the company to offer refunds only to customers who asked for them. CVS then sent letters to the customers that said they could call and discuss “your options,” and made no mention of the possibility of a refund. [More]
